Mixed options sentiment in Novo Nordisk (NVO), with shares down 12c near $46.65. Options volume relatively light with 44k contracts traded and calls leading puts for a put/call ratio of 0.48, compared to a typical level near 0.54. Implied volatility (IV30) is higher by 3.0 points near 37.66,in the bottom quartile of the past year, suggesting an expected daily move of $1.11. Put-call skew steepened, indicating increased demand for downside protection, following a downgrade to Hold at Argus.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NVO:
- Why is Biotech Stock iBio Up over 50%?
- Structure Therapeutics Stock (GPCR) Spikes 102% as Obesity Trial Beats Eli Lilly, Novo Nordisk
- Can Life Wave Sciences Disrupt the Obesity Market? WVE Soars 147% after Initial Results
- Novo Nordisk price target lowered to DKK 350 from DKK 500 at JPMorgan
- Novo Nordisk downgraded to Hold from Buy at Argus